Cite
Wang J, Liu Z, Zhang D, et al. FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties. Am J Transl Res. 2017;9(8):3676-3686
Wang, J., Liu, Z., Zhang, D., Liu, R., Lin, Q., Liu, J., Yang, Z., Ma, Q., Sun, D., Zhou, X., & Jiang, G. (2017). FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties. American journal of translational research, 9(8), 3676-3686.
Wang, Jin, et al. "FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties." American journal of translational research vol. 9,8 (2017): 3676-3686.
Wang J, Liu Z, Zhang D, Liu R, Lin Q, Liu J, Yang Z, Ma Q, Sun D, Zhou X, Jiang G. FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties. Am J Transl Res. 2017 Aug 15;9(8):3676-3686. eCollection 2017. PMID: 28861158; PMCID: PMC5575181.
Copy
Download .nbib